HBOT for Age-Related Macular Degeneration in Concord, CA
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in Americans over 65 — and for the majority who have the dry form, no approved disease-modifying treatment currently exists. At NorCal Hyperbarics in Concord, Dr. John Toth offers HBOT as an adjunctive treatment targeting the outer retinal hypoxia and oxidative stress that drive AMD progression, with clinical evidence of visual function improvement in treated patients.
How Age-Related Macular Degeneration Affects Vision and Daily Life
Age-related macular degeneration advances slowly but relentlessly, producing visual changes that profoundly affect independence and quality of life:
Central Vision Loss
Blurred central vision: Objects directly in front become increasingly unclear while peripheral vision remains intact — making reading, driving, and recognizing faces progressively impossible.
Metamorphopsia (distorted vision): Straight lines appear wavy or bent on Amsler grid testing — an early warning sign of advancing macular disease.
Scotoma (blind spots): Dark or empty areas in the center of the visual field that expand as geographic atrophy progresses in dry AMD or as subretinal scarring occurs in wet AMD.
Reduced contrast sensitivity: Difficulty distinguishing objects from similar-colored backgrounds, affecting safety in daily tasks long before acuity measurements capture the change.
Functional and Emotional Impact
Loss of independence: Inability to drive, read, manage finances, or recognize family members significantly erodes autonomy and increases reliance on caregivers.
Depression and social withdrawal: Vision loss from AMD carries a clinically significant depression risk — patients who lose the ability to engage in meaningful activities experience profound loss of identity and connection.
Falls and safety risk: Reduced central and contrast vision substantially increases fall risk in older adults, with direct consequences for health and independence.
Understanding Age-Related Macular Degeneration (AMD)
Age-related macular degeneration (AMD) is the progressive degeneration of the macula — the central, highest-acuity region of the retina responsible for reading, driving, and face recognition. It is the leading cause of irreversible vision loss in people over 65 in developed countries, affecting an estimated 20 million Americans. AMD occurs in two forms: dry AMD (also called non-neovascular AMD), which accounts for approximately 85 to 90% of cases and progresses through accumulation of drusen deposits and eventual geographic atrophy; and wet AMD (neovascular AMD), which accounts for 10 to 15% of cases but is responsible for the majority of severe vision loss, caused by pathological growth of abnormal blood vessels beneath the retina.
Current treatment options are markedly limited. Wet AMD is treated with anti-VEGF injections (ranibizumab, bevacizumab, aflibercept) that can slow neovascular progression but require indefinite repeat treatment and do not address the underlying ischemia. For dry AMD, no disease-modifying treatment has been approved — supplements (AREDS2 formula) may slow some forms of progression, but the majority of patients with geographic atrophy have no pharmacological options. This unmet need is the primary reason patients and physicians are exploring HBOT as a therapeutic adjunct.
The Bay Area's aging and health-conscious population creates significant demand for vision-preserving interventions. Contra Costa County's residents over 65 represent a growing demographic for whom maintaining visual independence is a critical quality-of-life priority.
How HBOT Addresses the Outer Retinal Hypoxia Driving AMD
The outer retina — comprising the photoreceptors and the retinal pigment epithelium (RPE) below them — is the most metabolically active tissue in the human body relative to its size, consuming more oxygen per unit weight than the brain or heart. This oxygen is supplied by diffusion from the underlying choroidal circulation through Bruch's membrane. As Bruch's membrane thickens with age and accumulates drusen (lipid deposits), oxygen diffusion is progressively impaired. The resulting outer retinal hypoxia drives the oxidative stress, complement activation, and RPE dysfunction that define AMD pathology. HBOT directly addresses this oxygen delivery failure.
At 1.5 to 2.0 atmospheres of 100% oxygen, HBOT raises the partial pressure of dissolved oxygen in the blood to levels sufficient to restore the oxygen gradient across even a thickened, drusen-laden Bruch's membrane. This oxygen reaches the photoreceptors and RPE cells through diffusion rather than through vascular delivery, bypassing the choroidal perfusion limitation that standard AMD therapies cannot address. The resulting improvement in RPE metabolic function reduces drusen accumulation, decreases complement pathway activation, and may slow the progression of geographic atrophy in dry AMD.
Multiple peer-reviewed studies have documented improvements in visual acuity, contrast sensitivity, Amsler grid distortion, and electroretinogram amplitude in AMD patients treated with HBOT. A study published in the Journal of Applied Physiology found that AMD patients treated with HBOT showed significant improvements in visual acuity that persisted beyond the treatment period. For wet AMD patients receiving anti-VEGF injections, HBOT addresses the underlying ischemic driver that these injections alone do not correct, providing complementary benefit. Dr. Toth designs individualized protocols, typically 20 to 30 sessions, coordinated with the patient's retinal specialist.
Benefits of HBOT for Age-Related Macular Degeneration
HBOT addresses the core pathophysiology driving AMD — outer retinal hypoxia and oxidative stress — rather than simply managing symptoms or blocking a single pathway.
Restored Oxygen Supply to the Outer Retina
The outer retina — where photoreceptors and the RPE reside — has the highest oxygen demand of any tissue in the body and is critically dependent on oxygen diffusion from the choroidal vasculature. HBOT directly restores the oxygen gradient across Bruch's membrane, providing the photoreceptors and RPE cells with the metabolic support they need to survive and function.
Reduced Oxidative Stress and Retinal Inflammation
HBOT reduces oxidative stress-driven retinal pigment epithelium degeneration, downregulates the complement pathway activation that contributes to drusen formation and RPE loss in geographic atrophy, and reduces the inflammatory signaling driving photoreceptor death.
Measurable Visual Function Improvement
Multiple clinical studies have documented improvements in visual acuity, contrast sensitivity, and Amsler grid performance in AMD patients following HBOT, with measurable functional benefits that exceed what anti-VEGF therapy alone achieves in many dry AMD patients.
Disease Stabilization in Dry AMD
For dry AMD — which has no approved disease-modifying treatment — HBOT offers the possibility of slowing geographic atrophy progression by maintaining the metabolic viability of surviving photoreceptors and RPE cells in at-risk regions adjacent to existing lesions.
How To Get Started with Your Tailored Hyperbaric Oxygen Therapy Sessions
From comprehensive assessments to personalized treatments and ongoing support, our approach ensures that every stage is aligned with your specific needs, helping you heal faster, feel stronger, and achieve lasting results.
Thorough Health Assessments to Understand Your Unique Needs
Developing a Hyperbaric Oxygen Therapy Regimen Just for You
Providing Support Throughout Your Healing Journey
Increase Your Healthspan with our core services
Our highly effective, personalized program don’t just help reverse aging. They enhance physical and cognitive performance as you age, so you can remain active and vital
Advanced Hyperbaric Oxygen Therapy for Healing and Recovery
Restore Balance with Hormone Replacement Therapy
Revitalize with Personalized IV Infusion Therapy
Healing Journeys with NorCal Hyperbaric
Discover how our personalized care has positively impacted the lives and well-being of our patients.
Molly G
Dr. Toth is fantastic! He skillfully treated my painful bursitis with professionalism and care. The procedure was painless, and I highly recommend him
Susan T
Dr. Toth and his office staff are wonderful! I've been a patient for over 20 years and he is incredibly knowledgable, compassionate and kind.
Jay Justin N
He removed a wart. Great doc. Sense of humor and with an admirable bedside manner. Procedure went off without a hitch. I highly recommend Dr Toth.
Norman P
Dr. Toth has been my "flight doctor" every year since 1992. It has always been easy to get an appointment. and the exam quite routine with no complications.
Anyes S
Great Doctor, not covered by our HMO but glad to pay and be treated the right way. Did a fantastic job with my teen. Took his time to understand, listen and find a solution.
Arash K
Visiting Dr. Toth for my FAA medical was a super laid-back and enjoyable experience. I would recommend him to anyone! Super friendly staff, too.
Begin Your Healing Journey with NorCal Hyperbarics
Declining health isn’t permanent. Whether addressing specific challenges or age-related changes, NorCal Hyperbaric’s personalized therapy can enhance your quality of life.
